Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024:
Situs Inversus Cases Rise After China Lifts Zero-COVID Policy
There was a “striking increase” in the number of cases of fetal situs inversus at two Chinese obstetric centers after the zero-COVID policies were lifted